Brief: Paradigm Biopharmaceuticals Requests Trading Halt
22/04/2026 23:49
April 23 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX: REQUESTS TRADING HALT PENDING CAPITAL RAISING ANNOUNCEMENT Further company coverage: PAR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt